首页> 美国卫生研究院文献>Molecules >Design Synthesis and Anti-Proliferative Activities of 26-Substituted Thieno32-dpyrimidine Derivatives Containing Electrophilic Warheads
【2h】

Design Synthesis and Anti-Proliferative Activities of 26-Substituted Thieno32-dpyrimidine Derivatives Containing Electrophilic Warheads

机译:含有亲电子战斗部的26-取代的噻吩并32-d嘧啶衍生物的设计合成和抗增殖活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thieno[3,2-d]pyrimidine as an effective pharmacophore has been extensively studied. However, its 2,6-substituted derivatives are rarely reported. In the present study, eighteen 2,6-substituted thieno[3,2-d]pyrimidine derivatives containing electrophilic warheads were designed based on the first known Fibroblast growth factor receptor-4 (FGFR4) inhibitor Blu9931. Unexpectedly, all of the derivatives exhibited negligible activity against FGFR4. However, most of the target compounds exhibited antiproliferative activities against four human cancer cell lines, including A431, NCI-H1975, Ramos and SNU-16. Compound >12 showed the most potent antiproliferative activities on the above four cell lines with IC50 values of 1.4 μM, 1.2 μM, 0.6 μM, and 2.6 μM, respectively. Additionally, the antiproliferative activity of >12 against MDA-MB-221 proved that >12 had the selectivity towards certain tumor cell lines. Furthermore, preliminary structure-activity relationship analysis was discussed based on the experimental data.
机译:噻吩并[3,2-d]嘧啶作为一种有效的药效团已被广泛研究。但是,很少报道其2,6-取代的衍生物。在本研究中,基于第一个已知的成纤维细胞生长因子受体4(FGFR4)抑制剂Blu9931设计了18种含有亲电战斗部的2,6-取代的噻吩并[3,2-d]嘧啶衍生物。出乎意料的是,所有衍生物对FGFR4的活性都可忽略不计。但是,大多数目标化合物对四种人类癌细胞系(包括A431,NCI-H1975,Ramos和SNU-16)都具有抗增殖活性。化合物> 12 对上述四种细胞系表现出最强的抗增殖活性,IC50值分别为1.4μM,1.2μM,0.6μM和2.6μM。另外,> 12 对MDA-MB-221的抗增殖活性证明> 12 对某些肿瘤细胞系具有选择性。此外,基于实验数据讨论了初步的构效关系分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号